J V Kras1, S Kartha2, B A Winkelstein3. 1. Department of Bioengineering, University of Pennsylvania, Philadelphia, PA 19104, USA. Electronic address: jkras@seas.upenn.edu. 2. Department of Bioengineering, University of Pennsylvania, Philadelphia, PA 19104, USA. Electronic address: skartha@seas.upenn.edu. 3. Department of Bioengineering, University of Pennsylvania, Philadelphia, PA 19104, USA; Department of Neurosurgery, University of Pennsylvania, Philadelphia, PA 19104, USA. Electronic address: winkelst@seas.upenn.edu.
Abstract
OBJECTIVE: The objective of the current study is to define whether intra-articular nerve growth factor (NGF), an inflammatory mediator that contributes to osteoarthritic pain, is necessary and sufficient for the development or maintenance of injury-induced facet joint pain and its concomitant spinal neuronal hyperexcitability. METHOD: Male Holtzman rats underwent painful cervical facet joint distraction (FJD) or sham procedures. Mechanical hyperalgesia was assessed in the forepaws, and NGF expression was quantified in the C6/C7 facet joint. An anti-NGF antibody was administered intra-articularly in additional rats immediately or 1 day following facet distraction or sham procedures to block intra-articular NGF and test its contribution to initiation and/or maintenance of facet joint pain and spinal neuronal hyperexcitability. NGF was injected into the bilateral C6/C7 facet joints in separate rats to determine if NGF alone is sufficient to induce these behavioral and neuronal responses. RESULTS: NGF expression increases in the cervical facet joint in association with behavioral sensitivity after that joint's mechanical injury. Intra-articular application of anti-NGF immediately after a joint distraction prevents the development of both injury-induced pain and hyperexcitability of spinal neurons. Yet, intra-articular anti-NGF applied after pain has developed does not attenuate either behavioral or neuronal hyperexcitability. Intra-articular NGF administered to the facet in naïve rats also induces behavioral hypersensitivity and spinal neuronal hyperexcitability. CONCLUSION: Findings demonstrate that NGF in the facet joint contributes to the development of injury-induced joint pain. Localized blocking of NGF signaling in the joint may provide potential treatment for joint pain.
OBJECTIVE: The objective of the current study is to define whether intra-articular nerve growth factor (NGF), an inflammatory mediator that contributes to osteoarthritic pain, is necessary and sufficient for the development or maintenance of injury-induced facet joint pain and its concomitant spinal neuronal hyperexcitability. METHOD: Male Holtzman rats underwent painful cervical facet joint distraction (FJD) or sham procedures. Mechanical hyperalgesia was assessed in the forepaws, and NGF expression was quantified in the C6/C7 facet joint. An anti-NGF antibody was administered intra-articularly in additional rats immediately or 1 day following facet distraction or sham procedures to block intra-articularNGF and test its contribution to initiation and/or maintenance of facet joint pain and spinal neuronal hyperexcitability. NGF was injected into the bilateral C6/C7 facet joints in separate rats to determine if NGF alone is sufficient to induce these behavioral and neuronal responses. RESULTS:NGF expression increases in the cervical facet joint in association with behavioral sensitivity after that joint's mechanical injury. Intra-articular application of anti-NGF immediately after a joint distraction prevents the development of both injury-induced pain and hyperexcitability of spinal neurons. Yet, intra-articular anti-NGF applied after pain has developed does not attenuate either behavioral or neuronal hyperexcitability. Intra-articularNGF administered to the facet in naïve rats also induces behavioral hypersensitivity and spinal neuronal hyperexcitability. CONCLUSION: Findings demonstrate that NGF in the facet joint contributes to the development of injury-induced joint pain. Localized blocking of NGF signaling in the joint may provide potential treatment for joint pain.
Authors: P J Dyck; S Peroutka; C Rask; E Burton; M K Baker; K A Lehman; D A Gillen; J L Hokanson; P C O'Brien Journal: Neurology Date: 1997-02 Impact factor: 9.910
Authors: S E Bove; S L Calcaterra; R M Brooker; C M Huber; R E Guzman; P L Juneau; D J Schrier; K S Kilgore Journal: Osteoarthritis Cartilage Date: 2003-11 Impact factor: 6.576
Authors: Sagar Singh; Sonia Kartha; Ben A Bulka; Nicholas S Stiansen; Beth A Winkelstein Journal: Clin Biomech (Bristol, Avon) Date: 2018-01-31 Impact factor: 2.063
Authors: Sonia Kartha; Ben A Bulka; Nick S Stiansen; Harrison R Troche; Beth A Winkelstein Journal: J Biomech Eng Date: 2018-08-01 Impact factor: 2.097
Authors: Jean-Marc G Guedon; Geraldine Longo; Lisa A Majuta; Michelle L Thomspon; Michelle N Fealk; Patrick W Mantyh Journal: Pain Date: 2016-06 Impact factor: 7.926